Multiple Sclerosis Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial By John Fleming On Oct 25, 2017 0 Share Multiple Sclerosis Journal, Ahead of Print. Read More... msmultiple sclerosisprimary progressiverrmssecondary progressive 0 Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail
